• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer.

作者信息

Gandaglia Giorgio, Barletta Francesco, Briganti Alberto, Montorsi Francesco

机构信息

Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

出版信息

Eur Urol. 2025 Mar;87(3):372-373. doi: 10.1016/j.eururo.2024.09.015. Epub 2024 Sep 26.

DOI:10.1016/j.eururo.2024.09.015
PMID:39332930
Abstract
摘要

相似文献

1
Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer.回复：NRG肿瘤学RTOG 0415的长期分析：一项比较低风险前列腺癌患者两种分割方案的随机III期非劣效性研究。
Eur Urol. 2025 Mar;87(3):372-373. doi: 10.1016/j.eururo.2024.09.015. Epub 2024 Sep 26.
2
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.NRG Oncology RTOG 0415 长期分析：一项比较低危前列腺癌患者两种分割方案的随机 III 期非劣效性研究。
J Clin Oncol. 2024 Jul 10;42(20):2377-2381. doi: 10.1200/JCO.23.02445. Epub 2024 May 17.
3
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.基因组分类器在中危前列腺癌中的性能：NRG 肿瘤学/RTOG 0126 随机 3 期试验的结果。
Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):370-377. doi: 10.1016/j.ijrobp.2023.04.010. Epub 2023 May 2.
4
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials.预测前列腺癌放疗的剂量反应：在随机III期NRG/RTOG 0126和SAKK 09/10试验中验证一种辐射特征
Ann Oncol. 2025 May;36(5):572-582. doi: 10.1016/j.annonc.2025.01.017. Epub 2025 Feb 13.
5
Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927).
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):638. doi: 10.1016/j.ijrobp.2015.11.031.
6
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.基于活检的基因组分类器在高危前列腺癌中的分析：NRG 肿瘤学/放射肿瘤学组 9202、9413 和 9902 期随机试验的荟萃分析。
Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):521-529. doi: 10.1016/j.ijrobp.2022.12.035. Epub 2022 Dec 31.
7
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.长期激素治疗（与短期激素治疗相比）的效果：对接受NRG肿瘤学RTOG 9202治疗的中危前列腺癌患者的二次分析
Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):511-515. doi: 10.1016/j.ijrobp.2016.11.002. Epub 2016 Nov 8.
8
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.多西他赛化疗联合雄激素抑制和放疗治疗局限性高危前列腺癌的效果：NRG 肿瘤学 RTOG 0521 随机 III 期试验。
J Clin Oncol. 2019 May 10;37(14):1159-1168. doi: 10.1200/JCO.18.02158. Epub 2019 Mar 12.
9
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.基于前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的复发性前列腺癌患者挽救性放疗淋巴结图谱：新的NRG肿瘤学2020指南的验证
Eur Urol Oncol. 2022 Dec;5(6):668-676. doi: 10.1016/j.euo.2022.09.006. Epub 2022 Oct 21.
10
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.NRG 肿瘤学/RTOG-0129 风险组在 HPV 阳性和 HPV 阴性口咽鳞状细胞癌中的验证：对基于风险的治疗强度试验的影响。
Cancer. 2019 Jun 15;125(12):2027-2038. doi: 10.1002/cncr.32025. Epub 2019 Mar 26.